Key facts
- Notable investors include Carinthian Venture Fonds.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Ennocure
- ·The full record, as it builds
Funding rounds
No funding rounds for Ennocure are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ennocure
Developer of a bio-electronic wound management system intended to support personalized and continuously monitored treatment of chronic and acute wounds. The company provides real time wound monitoring, AI-driven therapy adjustments, and digitalized healing insights, enabling clinicians to improve treatment precision and patient outcomes.
- Sector
- Healthcare
- HQ
- Israel
- Founded
- 2022
- Website
- ennocure.com/
- Ownership
- Privately Held (backing)
Ennocure doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ennocure shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ennocure in its N-PORT filings yet. We sweep new filings monthly.